Author
Listed:
- Ethan A. Englund
(Laboratory of Bioorganic Chemistry, NIDDK, NIH, Bethesda, Maryland 20892, USA.)
- Deyun Wang
(Laboratory of Bioorganic Chemistry, NIDDK, NIH, Bethesda, Maryland 20892, USA.)
- Hidetsugu Fujigaki
(Laboratory of Cell Biology, CCR, NCI, NIH, Bethesda, Maryland 20892, USA.
Present address: Faculty of Health Sciences, Hiroshima International University, Hiroshima 739-2695, Japan.)
- Hiroyasu Sakai
(Laboratory of Cell Biology, CCR, NCI, NIH, Bethesda, Maryland 20892, USA.)
- Christopher M. Micklitsch
(Laboratory of Bioorganic Chemistry, NIDDK, NIH, Bethesda, Maryland 20892, USA.)
- Rodolfo Ghirlando
(Laboratory of Molecular Biology, NIDDK, NIH, Bethesda, Maryland 20892, USA.)
- Gema Martin-Manso
(Laboratory of Pathology, CCR, NCI, NIH, Bethesda, Maryland 20892, USA.)
- Michael L. Pendrak
(Laboratory of Pathology, CCR, NCI, NIH, Bethesda, Maryland 20892, USA.)
- David D. Roberts
(Laboratory of Pathology, CCR, NCI, NIH, Bethesda, Maryland 20892, USA.)
- Stewart R. Durell
(Laboratory of Cell Biology, CCR, NCI, NIH, Bethesda, Maryland 20892, USA.)
- Daniel H. Appella
(Laboratory of Bioorganic Chemistry, NIDDK, NIH, Bethesda, Maryland 20892, USA.)
Abstract
Multivalent effects dictate the binding affinity of multiple ligands on one molecular entity to receptors. Integrins are receptors that mediate cell attachment through multivalent binding to peptide sequences within the extracellular matrix, and overexpression promotes the metastasis of some cancers. Multivalent display of integrin antagonists enhances their efficacy, but current scaffolds have limited ranges and precision for the display of ligands. Here we present an approach to studying multivalent effects across wide ranges of ligand number, density, and three-dimensional arrangement. Using L-lysine γ-substituted peptide nucleic acids, the multivalent effects of an integrin antagonist were examined over a range of 1–45 ligands. The optimal construct improves the inhibitory activity of the antagonist by two orders of magnitude against the binding of melanoma cells to the extracellular matrix in both in vitro and in vivo models.
Suggested Citation
Ethan A. Englund & Deyun Wang & Hidetsugu Fujigaki & Hiroyasu Sakai & Christopher M. Micklitsch & Rodolfo Ghirlando & Gema Martin-Manso & Michael L. Pendrak & David D. Roberts & Stewart R. Durell & Da, 2012.
"Programmable multivalent display of receptor ligands using peptide nucleic acid nanoscaffolds,"
Nature Communications, Nature, vol. 3(1), pages 1-7, January.
Handle:
RePEc:nat:natcom:v:3:y:2012:i:1:d:10.1038_ncomms1629
DOI: 10.1038/ncomms1629
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:3:y:2012:i:1:d:10.1038_ncomms1629. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.